Skip to main content

Tobira Therapeutics Taps Pharsight's PKS Online to Support HIV Drug Development


Pharsight, a St. Louis, Mo.-based software firm, said this week that Tobira Therapeutics has selected PKS Online to support its HIV drug development efforts.

Tobira will use the software to analyze, manage, and report data for its HIV drug candidate cenicriviroc, an antagonist of both CCR5, a co-receptor that’s required for HIV infection, and CCR2, a co-receptor that is involved in a number of metabolic and cardiovascular diseases. The drug is currently in Phase 2 clinical development.

David Martin, Tobira's senior vice president of drug development and regulatory affairs, said that PKS Online "[eliminates] the need for deployment, validation, and management of an in-house system."

"With PKS Online, I have real-time visibility and streamlined access to time-critical analyses and study results, available on my desktop, to readily share with our management team, scientific advisors, and other key stakeholders," he said in a statement.

PKS Online is a software-as-a-service implementation of Pharsight Knowledgebase Server, an enterprise data management system for storing and tracking pharmacokinetic and pharmacodynamic data and analyses.

Among other features, the system lets users export studies in the Clinical Data Interchange Standards Consortium format for regulatory submission as well as simplify data-management tasks required to create multi-study analyses and prepare pharmacometric models.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.